ArticleJournal of cannabis research2025
What proportion of people who use cannabis in Germany have spoken with their general practitioner about their consumption? A repeated cross-sectional representative population survey.
Article in Journal of cannabis research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionOn April 1st, 2024, Germany's cannabis legalisation bill entered into force. It is unknown what effect the legal changes could have, if any, on the prevalence of cannabis use. Preventive measures of cannabis-related health impacts are best possible if harmful use is recognised and addressed at an early stage. Our aim was to estimate the proportion of people who used cannabis in Germany that discussed their cannabis consumption with their general practitioner (GP), on the initiative of either the GP or the patient, and how these varied according to person characteristics.
methodsWe used data from the German Study on Tobacco Use (DEBRA). This is a repeated ongoing representative cross-sectional household survey on the use of tobacco and alternative nicotine delivery systems in Germany in people aged 14 years and older. In bi-monthly study waves we asked all respondents who stated that they had consumed cannabis before whether they had ever spoken with their GP about their cannabis use or received advice about it. We estimated the proportion including 95% confidence intervals and assessed possible associations with person characteristics using univariate logistic regression models.
resultsOf 2,057 people who have ever used cannabis, 7.0% [95%CI = 5.9; 8.2%] (n = 139) reported having spoken to their general practitioner about their cannabis use or having sought advice in this regard. This response was associated with older age (65 +), low educational attainment, low income and frequent cannabis use. Conversation with a GP was also more common among people who had used cannabis in the past year (16.2%; 95%CI = 13.5; 19.6%).
conclusionsAround one in fifteen people who have used cannabis before has ever spoken with his or her GP, or received advice, about his or her cannabis consumption. In people with past-year and especially frequent use, the proportions are highest, ranging between 16 to 26%. The awareness of this topic among GPs needs to be increased. Furthermore, a future re-evaluation of what impact cannabis legalisation will have on the frequency of consultation about cannabis consumption in primary care is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.